
Effects of SLU-PP-332 on Liver and Lipids
SLU-PP-332 appears to have potentially favorable effects on liver fat and systemic lipid metabolism in mice, but the evidence is still preclinical. Importantly, SLU-PP-332 is an ERRα/β/γ agonist, not a PPAR agonist, so PPAR findings should be treated as mechanistic…









